Renaissance Technologies LLC Makes New Investment in Tyra Biosciences, Inc. (NASDAQ:TYRA)

Renaissance Technologies LLC bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 29,100 shares of the company's stock, valued at approximately $404,000. Renaissance Technologies LLC owned 0.06% of Tyra Biosciences at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. KLP Kapitalforvaltning AS acquired a new position in Tyra Biosciences in the fourth quarter valued at about $31,000. US Bancorp DE acquired a new stake in shares of Tyra Biosciences during the fourth quarter worth $50,000. Wells Fargo & Company MN lifted its position in Tyra Biosciences by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 9,493 shares of the company's stock valued at $132,000 after acquiring an additional 3,236 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Tyra Biosciences by 130,587.5% during the 4th quarter. Russell Investments Group Ltd. now owns 10,455 shares of the company's stock worth $145,000 after purchasing an additional 10,447 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new stake in shares of Tyra Biosciences in the fourth quarter valued at about $149,000. Institutional investors own 84.14% of the company's stock.

Wall Street Analysts Forecast Growth

TYRA has been the subject of several research reports. HC Wainwright reaffirmed a "buy" rating and set a $30.00 price target on shares of Tyra Biosciences in a research note on Monday, March 31st. Wedbush restated an "outperform" rating and issued a $30.00 price objective on shares of Tyra Biosciences in a report on Friday, March 28th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Tyra Biosciences has a consensus rating of "Buy" and an average target price of $30.83.

Tyra Biosciences Trading Up 2.5 %

Tyra Biosciences stock traded up $0.25 during trading hours on Friday, reaching $10.32. 148,432 shares of the stock were exchanged, compared to its average volume of 257,435. Tyra Biosciences, Inc. has a twelve month low of $6.42 and a twelve month high of $29.60. The stock has a 50 day moving average of $9.66 and a two-hundred day moving average of $13.43. The company has a market cap of $547.89 million, a P/E ratio of -6.41 and a beta of 1.17.

Tyra Biosciences (NASDAQ:TYRA - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.49) by $0.02. On average, analysts expect that Tyra Biosciences, Inc. will post -1.57 earnings per share for the current fiscal year.

Tyra Biosciences Company Profile

Tyra Biosciences, Inc, a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.